Doctors should rethink their demand that patients finish prescribed courses of antibiotics, senior specialists – controversially – say today.
The specialists, including two professors of infectious diseases, say there is no evidence that completing prescriptions is necessary to prevent drug resistance.
But GP leaders today say there is also no evidence to change the standard advice – that patients should complete the prescription.
The controversial case is made today in The BMJ by a group led by Professor Martin Llewelyn, professor of infectious diseases at the Brighton and Sussex Medical School, UK, and Professor Tim Peto, professor of infectious diseases in Oxford, UK.
The group accepts that TB treatment is an exception to their argument.
They write: "The idea that stopping antibiotic treatment early encourages antibiotic resistance is not supported by evidence, while taking antibiotics for longer than necessary increases the risk of resistance."
But Royal College of GPs chair Professor Helen Stokes-Lampard said: “Recommended courses of antibiotics are not random. They are tailored to individual conditions and in many cases, courses are quite short – for urinary tract infections, for example, three days is often enough to cure the infection.
"We are concerned about the concept of patients stopping taking their medication mid-way through a course once they feel better, because improvement in symptoms does not necessarily mean the infection has been completely eradicated."
She added: “It’s important that patients have clear messages and the mantra to always take the full course of antibiotics is well known – changing this will simply confuse people.
“We agree with the researchers that more high quality, clinical trials are needed – and when guidelines are updated, they should take all new evidence into account. But we’re not at that stage yet."
The antibiotic course has had its day. BMJ 27 July 2017 [abstract]

Leave a Reply